Nanoparticles, neurotoxicity and neurodegenerative diseases

Current Drug Metabolism

Volumn 16, Issue 8, 2015, Pages 676-684

  Mushtaq, Gohar ^a,b   Khan, Jalaluddin A ^a   Joseph, Ebenezer ^c   Kamal, Mohammad A ^a,d  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b LC MS Metabolite Identification Division   (United States)

^c UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

^d Enzymoics   (Australia)

Author keywords

Alzheimer's disease; Microglia activation; Nanoparticles; Neurodegenerative; Oxidative stress; Parkinson's disease

Indexed keywords

NANOPARTICLE;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; COGNITION; DEGENERATIVE DISEASE; DNA DAMAGE; HUMAN; LIPID PEROXIDATION; MENTAL DETERIORATION; MICROGLIA; MOTOR PERFORMANCE; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; ANIMAL; CHEMICALLY INDUCED; NEUROTOXICITY SYNDROMES;

ANIMALS; HUMANS; NANOPARTICLES; NEURODEGENERATIVE DISEASES; NEUROTOXICITY SYNDROMES;

EID: 84947928728     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200216666150812122302     Document Type: Article

References (112)

1. Oberdorster, G.; Oberdorster, E.; Oberdorster, J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect., 2005, 113, 823-839.
2. Nemmar, A.; Inuwa, I. M. Diesel exhaust particles in blood trigger systemic and pulmonary morphological alterations. Toxicol. Lett., 2008, 176, 20-30
3. Burch, W. M. Passage of inhaled particles into the blood circulation in humans. Circulation, 2002, 106, 141-142.
4. Oberdorster, G.; Sharp, Z.; Atudorei, V.; Elder, A.; Gelein, R.; Kreyling, W.; Cox, C. Translocation of inhaled ultrafine particles to the brain. Inhal. Toxicol., 2004, 16, 437-445
5. Maynard, A. D.; Warheit, D. B.; Philbert, M. A. The new toxicology of sophisticated materials: Nanotoxicology and beyond. Toxicol. Sci., 2011, 120, 109-129.
6. Robichaud, C. O.; Tanzil, D.; Weilenmann, U.; Wiesner, M. R. Relative risk analysis of several manufactured nanomaterials: An insurance industry context. Environ. Sci. Technol., 2005, 39, 8985-8994.
7. Obersdorster, G.; Sharp, Z.; Atudorei, V.; Elder, A.; Gelein, R.; Kreyling, W.; Cox, C. Translocation of inhaled ultrafine particles to the brain. Inhalation Toxicol., 2004, 16, 437-445.
8. Lockman, P. R.; Koziara, J. M.; Mumper, R. J.; Allen, D. D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J. Drug Target, 2004, 12, 635-641.
9. Yang, Z.; Liu, Z. W.; Allaker, R. P.; Reip, P.; Oxford, J.; Ahmad, Z.; Ren, G. A review of nanoparticle functionality and toxicity on the central nervous system. J. R. Soc. Interface, 2010, 7, 411-422.
10. Win-Shwe, T. T.; Fujimaki, H. Nanoparticles and neurotoxicity. Int. J. Mol. Sci., 2011, 12, 6267-6268.
11. Morimoto, Y.; Kobayashi, N.; Shinohara, N.; Myojo, T.; Tanaka, I.; Nakanishi, J. Hazard assessments of manufactured nanomaterials. J. Occup. Health, 2010, 52, 325-334.
12. Hu, Y. L.; Gao, J. Q. Potential neurotoxicity of nanoparticles. In. J. Pharm., 2010, 394, 115-121.
13. Przedborski, S.; Vila, M.; Jackson-Lewis, V. Neurodegeneration: What is it and where are we? J. Clin. Invest., 2003, 111, 3-10.
14. Alzheimer's Association 2010 Alzheimer's Disease: Facts and Figures. Alzheimer's Association, Chicago, IL. 2010.
15. Qiu, C.; De Ronchi, D.; Fratiglioni, L. The epidemiology of the dementias: an update. Curr. Opin. Psychiatry, 2007, 20, 380-385
16. Molsa, P. K.; Marttila, R. J.; Rinne, U. K. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol. Scand., 1986, 74, 103-107.
17. Molsa, P. K.; Marttila, R. J.; Rinne, U. K. Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia. Acta Neurol. Scand., 1995, 91, 159-164.
18. Hirtz, D.; Thurman, D. J.; Gwinn-Hardy, K.; Mohamed, M.; Chaudhuri, A. R.; Zalutsky, R. How common are the "common" neurologic disorders? Neurology, 2007, 68, 326-337.
19. Thomas, B.; Beal, M. F. Parkinson's disease. Hum. Mol. Genet., 2007, 16(S2), R183-R194
20. Goetz, C. G. The history of Parkinson's disease: Early clinical descriptions and neurological therapies. Cold Spring Harb. Perspect. Med., 2011, 1(1), a008862.
21. Mates, J. M; Perez-Gomez, C.; Nunez de Castro, I. Antioxidant enzymes and human diseases. Clin. Biochem., 1999, 32, 595-603.
22. Orringer, D; Koo, Y. E; Chen, T.; Kopelman, R.; Sagher, O.; Philbert, M. A. Small solutions for big problems: The application of nanoparticles to brain tumor diagnosis and therapy. Clin. Pharmacol. Ther., 2009, 85, 531-534.
23. Iqbal, A.; Ahmad, I.; Khalid, M. H.; Nawaz, M. S.; Gan, S. H.; Kamal, M. A. Nanoneurotoxicity to nanoneuroprotection using biological & computational approaches. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 2013, 31(3), 256-284.
24. Calderon-Garciduenas, L; Reed, W; Maronpot, R. R; Henríquez-Roldán, C.; Delgado-Chavez, R.; Calderón-Garcidueñas, A.; Dragustinovis, I.; Franco-Lira, M.; Aragón-Flores, M.; Solt, A. C.; Altenburg, M.; Torres-Jardón, R.; Swenberg, J. A. Brain inflammation and Alzheimer's-like pathology in individuals exposed to severe air pollution. Toxicol. Pathol., 2004, 32, 650-658.
25. Borm, P. J.; Kreyling, W. Toxicological hazards of inhaled nanoparticles potential implications for drug delivery. J. Nanosci. Nanotechnol., 2004, 4, 521-531.
26. Veronesi, B.; Makwana, O.; Pooler, M; Chen, L. C. Effects of subchronic exposures to concentrated ambient particles. VII. Degeneration of dopaminergic neurons in Apo E-/-mice. Inhal. Toxicol., 2005, 17, 235-241.
27. Yamakoshi, Y.; Umezawa, N.; Ryu, A.; Arakane, K.; Miyata, N.; Goda, Y.; Masumizu, T.; Nagano, T. Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2 versus 1O2. J. Am. Chem. Soc., 2003, 125, 1283-1289.
28. Brown, D.; Stone, V.; Findlay, P.; MacNee, W.; Donaldson, K. Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup. Environ. Med., 2000, 57, 685-691.
29. Eckert, A.; Keil, U.; Marques, C. A.; Bonert, A.; Frey, C.; Schüssel, K.; Müller, W. E. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem. Pharmacol., 2003, 66(8), 1627-1634.
30. Halliwell, B. Oxidative stress and neurodegeneration: where are we now? J. Neurochem., 2006, 97(6), 1634-1658.
31. Mushtaq, G.; Khan, J. A.; Kamal, M. A. Biological Mechanisms linking Alzheimer's disease and Type 2 Diabetes Mellitus. CNS Neurol. Disord. Drug. Targets, 2014, 13, 1192-1201.
32. Peters, A.; Veronesi, B.; Calderón-Garcidueñas, L.; Gehr, P.; Chen, L. C.; Geiser, M.; Reed, W.; Rothen-Rutishauser, B.; Schürch, S.; Schulz, H. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part. Fibre Toxicol., 2006, 3, 13.
33. Sayes C. M.; Reed, K. L.; Warheit, D. B. Assessing Toxicity of Fine and Nanoparticles: Comparing in vitro Measurements to in vivo Pulmonary Toxicity Profiles. Toxicol. Sci., 2007, 97(1), 163.
34. Thomson, E. M. Kumarathasan, P.; Calderón-Garcidueñas, L.; Vincent, R. Air pollution alters brain and pituitary endothelin-1 and inducible nitric oxide synthase gene expression. Environ. Res., 2007, 105, 224-233.
35. Block, M. L.; Wu, X.; Pei, Z.; Li, G.; Wang, T.; Qin, L.; Wilson, B.; Yang, J.; Hong, J. S.; Veronesi, B. Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: The role of microglia, phagocytosis, and NADPH oxidase. FASEB J., 2004, 18, 1618-1620.
36. Panyala, N. R.; Pena-Mendez, E. M.; Havel, J. Silver or silver nanoparticles: A hazardous threat to the environment and human health. J. Appl. Biomed., 2008, 6, 117-129.
37. Rungby, J.; Danscher, G. Localization of exogenous silver in brain and spinal cord of silver exposed rats. Acta Neuropathol., 1983, 60, 92-98.
38. Rahman, M. F.; Wang, J.; Patterson, T. A.; Saini, U. T.; Robinson, B. L.; Newport, G. D.; Murdock, R. C.; Schlager, J. J.; Hussain, S. M.; Ali, S. F. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol. Lett., 2009, 187, 15-21.
39. Castranova, V.; Ma, J. Y.; Yang, H. M.; Antonini, J. M.; Butterworth, L.; Barger, M. W.; Roberts, J.; Ma, J. K. Effect of exposure to diesel exhaust particles on the susceptibility of the lung to infection. Environ. Health Perspect., 2001, 109 Suppl 4, 609-12.
40. Burton, N. C.; Guilarte, T. R. Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ. Health Perspect., 2009, 117, 325-332.
41. Lucchini, R.; Benedetti, L.; Borghesi, S.; Garattini, S.; Parrinello, G.; Alessio, L. Exposure to neurotoxic metals and prevalence of parkinsonian syndrome in the area of Brescia. G. Ital. Med. Lav. Ergon., 2003, 25 Suppl, 88-89.
42. Finkelstein, M.; Jerrett, M. A study of the relationships between Parkinson's disease and markers of traffic-derived environmental manganese air pollution in two Canadian cities. Environ. Res., 2007, 104, 420-432
43. Klein, W. L. Synaptic targeting by A beta oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease. Alzheimer's Dement., 2006, 2(1), 43-55.
44. Spillantini, M. G.; Schmidt, M. L.; Lee, V. M.; Trojanowski, J. Q.; Jakes, R.; Goedert, M. Alpha-synuclein in Lewy bodies. Nature, 1997, 388(6645), 839-840.
45. Qin, Z.; Hu, D.; Han, S.; Reaney, S. H.; Di Monte, D. A.; Fink, A. L. Effect of 4-hydroxy-2-nonenal modification on alphasynuclein aggregation. J. Biol. Chem., 2007, 282, 5862-5870.
46. Liu, L.; Komatsu, H.; Murray, I. V.; Axelsen, P. H. Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product. J. Mol. Biol., 2008, 377, 1236-1250.
47. Lynch, I.; Cedervall, T.; Lundqvist, M.; Cabaleiro-Lago, C.; Linse, S.; Dawson, K. A. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv. Colloid Interface Sci., 2007, 134-135, 167-174.
48. Colvin, V. L.; Kulinowski, K. M. Nanoparticles as catalysts for protein fibrillation. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 8679-8680.
49. Block, M. L.; Calderon-Garciduenas, L. Air pollution: mechanisms of neuroinflammation and CNS disease. Trends Neurosci., 2009, 32(9), 506-516.
50. Weuve, J.; Puett, R. C.; Schwartz, J.; Yanosky, J. D.; Laden, F.; Grodstein, F. Exposure to particulate air pollution and cognitive decline in older women. Arch. Intern. Med., 2012, 172(3), 219-227.
51. Power, M. C.; Weisskopf, M. G.; Alexeeff, S. E.; Coull, B. A.; Spiro, A. III.; Schwartz, J. Traffic-related air pollution and cognitive function in a cohort of older men. Environ. Health Perspect., 2011, 119(5), 682-687.
52. Zeng, Y.; Gu, D.; Purser, J.; Hoenig, H; Christakis, N. Associations of environmental factors with elderly health and mortality in China. Am. J. Public Health, 2010, 100(2), 298-305.
53. Alekseenko, A. V.; Waseem, T. V.; Fedorovich, S. V. Ferritin, a protein containing iron nanoparticles, induces reactive oxygen species formation and inhibits glutamate uptake in rat brain synaptosomes. Brain Res., 2008, 1241, 193-200.
54. Tang, M.; Xing, T.; Zeng, J.; Wang, H.; Li, C.; Yin, S.; Yan, D.; Deng, H.; Liu, J.; Wang, M.; Chen, J.; Ruan, D. Y. Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons. Environ. Health Perspect., 2008, 116, 915-922.
55. Calderon-Garciduenas, L.; Azzarelli, B.; Acuna, H.; Garcia, R.; Gambling, T. M.; Osnaya, N.; Monroy, S.; DEL Tizapantzi M. R.; Carson, J. L.; Villarreal-Calderon, A.; Rewcastle, B. Air pollution and brain damage. Toxicol. Pathol., 2002, 30, 373-389
56. Calderon-Garciduenas, L.; Maronpot, R. R.; Torres-Jardon, R.; Henríquez-Roldán, C.; Schoonhoven, R.; Acuña-Ayala, H.; Villarreal-Calderón, A.; Nakamura, J.; Fernando, R.; Reed, W.; Azzarelli, B.; Swenberg, J. A. DNA damage in nasal and brain tissues of canines exposed to air pollutants is associated with evidence of chronic brain inflammation and neurodegeneration. Toxicol. Pathol., 2003, 31, 524-538.
57. Calderon-Garciduenas, L. Mora-Tiscareño, A.; Ontiveros, E.; Gómez-Garza, G.; Barragán-Mejía, G.; Broadway, J.; Chapman, S.; Valencia-Salazar, G.; Jewells, V.; Maronpot, R. R.; Henríquez-Roldán, C.; Pérez-Guillé, B.; Torres-Jardón, R.; Herrit, L.; Brooks, D.; Osnaya-Brizuela, N.; Monroy, M. E.; González-Maciel, A.; Reynoso-Robles, R.; Villarreal-Calderon, R.; Solt, A. C.; Engle, R. W. Air pollution, cognitive deficits and brain abnormalities: a pilot study with children and dogs. Brain Cogn., 2008, 68, 117-127.
58. Łuczaj, W.; Skrzydlewska, E. DNA damage caused by lipid peroxidation products. Cell. Mol. Biol. Lett., 2003, 8(2), 391-413.
59. Adams, L. K.; Lyon, D. Y.; McIntosh, A.; Alvarez, P. J. Comparative toxicity of nano-scale TiO2, SiO2 and ZnO water suspensions. Water Sci. Technol., 2006, 54, 327-334.
60. Iavicoli, I.; Leso, V.; Fontana, L.; Bergamaschi, A. Toxicological effects of titanium dioxide nanoparticles: a review of in vitro mammalian studies. Eur. Rev. Med. Pharmacol. Sci., 2011, 15, 481-508.
61. Lovern, S. B.; Klaper, R. Daphnia magna mortality when exposed to titanium dioxide and fullerene (C60) nanoparticles. Environ. Toxicol. Chem., 2006, 25, 1132-1137.
62. Ireland, J. C., Klostermann, P., Rice, E. W., Clark, R. M. Inactivation of Escherichia coli by titanium dioxide photocatalytic oxidation. Appl. Environ. Microbiol., 1993, 59, 1668-1670.
63. Wang, J. Chen, C.; Liu, Y.; Jiao, F.; Li, W.; Lao, F.; Li, Y.; Li, B.; Ge, C.; Zhou, G.; Gao, Y.; Zhao, Y.; Chai, Z. Potential neurological lesion after nasal instillation of TiO (2) nanoparticles in the anatase and rutile crystal phases. Toxicol. Lett., 2008, 183, 72-80.
64. Trouiller, B.; Reliene, R.; Westbrook, A.; Solaimani, P.; Schiestl, R. H. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice Cancer Res., 2009, 69(22), 8784-8789.
65. Block, M. L.; Zecca, L.; Hong, J. S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci., 2007, 8, 57-69.
66. Mushtaq, G.; Khan, J. A.; Kumosani, T. A.; Kamal, M. A. Alzheimer's disease and Type 2 Diabetes via Chronic Inflammatory Mechanisms. Saudi J. Biol. Sci., 2015, 22, 4-13.
67. Craig, L.; Brook, JR.; Chiotti, Q.; Croes, B.; Gower, S.; Hedley, A.; Krewski, D.; Krupnick, A.; Krzyzanowski, M.; Moran, M. D.; Pennell, W.; Samet, J. M.; Schneider, J.; Shortreed, J.; Williams, M. Air pollution and public health: a guidance document for risk managers. J. Toxicol. Environ. Health A, 2008, 71, 588-698.
68. Riedl, M. A. The effect of air pollution on asthma and allergy. Curr. Allergy Asthma Rep., 2008, 8, 139-146.
69. Mills, N. L.; Donaldson, K.; Hadoke, P. W.; Boon, N. A.; MacNee, W.; Cassee, F. R.; Sandström, T.; Blomberg, A.; Newby, D. E. Adverse cardiovascular effects of air pollution. Nat. Clin. Pract. Cardiovasc. Med., 2009, 6, 36-44.
70. Akimoto, H. Global air quality and pollution. Science, 2003, 302, 1716-1719.
71. Rothen-Rutishauser, B.; Mueller, L.; Blank, F.; Brandenberger, C.; Muehlfeld, C.; Gehr, P. A newly developed in vitro model of the human epithelial airway barrier to study the toxic potential of nanoparticles. ALTEX, 2008, 25, 191-196.
72. Valavanidis, A. Fiotakis, K.; Vlachogianni, T. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev., 2008, 26, 339-362.
73. Simkhovich, B. Z. Kleinman, M. T.; Kloner, R. A. Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. J. Am. Coll. Cardiol., 2008, 52, 719-726.
74. Muhlfeld, C. Rothen-Rutishauser, B.; Blank, F.; Vanhecke, D.; Ochs, M.; Gehr, P. Interactions of nanoparticles with pulmonary structures and cellular responses. Am. J. Physiol. Lung Cell. Mol. Physiol., 2008, 294, L817-829.
75. Ruckerl, R. Greven S.; Ljungman, P.; Aalto, P.; Antoniades, C.; Bellander, T.; Berglind, N.; Chrysohoou, C.; Forastiere, F.; Jacquemin, B.; von Klot, S.; Koenig, W.; Küchenhoff, H.; Lanki, T.; Pekkanen, J.; Perucci, C. A.; Schneider, A.; Sunyer, J.; Peters, A. Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ. Health Perspect., 2007, 115, 1072-1080.
76. Swiston, J. R.; Davidson, W.; Attridge, S.; Li, G. T.; Brauer, M.; van Eeden, S. F. Wood smoke exposure induces a pulmonary and systemic inflammatory response in firefighters. Eur. Respir. J., 2008, 32, 129-138.
77. Folkmann, J. K.; Risom, L.; Hansen, C. S.; Loft, S.; Moller, P. Oxidatively damaged DNA and inflammation in the liver of dyslipidemic ApoE-/-mice exposed to diesel exhaust particles. Toxicology, 2007, 237, 134-144.
78. Tamagawa, E.; van Eeden, S. F. Impaired lung function and risk for stroke: role of the systemic inflammation response? Chest, 2006, 130, 1631-1633.
79. Manousakis, G.; Jensen, M. B.; Chacon, M. R.; Sattin, J. A.; Levine, R. L. The interface between stroke and infectious disease: infectious diseases leading to stroke and infections complicating stroke. Curr. Neurol. Neurosci. Rep., 2009, 9, 28-34.
80. Rivest, S.; Lacroix, S.; Vallières, L.; Nadeau, S.; Zhang, J.; Laflamme, N. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc. Soc. Exp. Biol. Med., 2000, 223, 22-38.
81. Kleinman, M. T.; Araujo, J. A.; Nel, A.; Sioutas, C.; Campbell, A.; Cong, P. Q.; Li, H.; Bondy, S. C. Inhaled ultrafine particulate matter affects CNS inflammatory processes and may act via MAP kinase signaling pathways. Toxicol. Lett., 2008, 178, 127-130.
82. Campbell, A.; Oldham, M.; Becaria, A.; Bondy, S. C.; Meacher, D.; Sioutas, C.; Misra, C.; Mendez, L. B.; Kleinman, M. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology, 2005, 26, 133-140.
83. Sirivelu, M. P.; Mohan Kumar, S. M.; Wagner, J. G.; Harkema, J. R.; Mohan Kumar, P. S. Activation of the stress axis and neurochemical alterations in specific brain areas by concentrated ambient particle exposure with concomitant allergic airway disease. Environ. Health Perspect., 2006, 114, 870-874.
84. Win-Shwe, T. T.; Mitsushima, D.; Yamamoto, S.; Fukushima, A.; Funabashi, T.; Kobayashi, T.; Fujimaki, H. Changes in neurotransmitter levels and proinflammatory cytokine mRNA expressions in the mice olfactory bulb following nanoparticle exposure. Toxicol. Appl. Pharmacol., 2008, 226, 192-198.
85. Calderon-Garciduenas, L.; Villarreal-Calderon, R.; Valencia-Salazar, G.; Henríquez-Roldán, C.; Gutiérrez-Castrellón, P.; Torres-Jardón, R.; Osnaya-Brizuela, N.; Romero, L.; Torres-Jardón, R.; Solt, A.; Reed, W. Systemic inflammation, endothelial dysfunction, and activation in clinically healthy children exposed to air pollutants. Inhal. Toxicol., 2008, 20, 499-506.
86. Qin, L.; Wu, X.; Block, M. L.; Liu, Y.; Breese, G. R.; Hong, J. S.; Knapp, D. J.; Crews, F. T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia, 2007, 55, 453-462.
87. Ling, Z.; Zhu, Y.; Tong, C. W.; Snyder, J. A.; Lipton, J. W.; Carvey, P. M. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally. Exp. Neurol., 2006, 199, 499-512.
88. Jacobs, L.; Nawrot, T. S.; de Geus, B.; Meeusen, R.; Degraeuwe, B.; Bernard, A.; Sughis, M.; Nemery, B.; Panis, L. I. Subclinical responses in healthy cyclists briefly exposed to traffic-related air pollution; an intervention study. Environ. Health, 2010, 9, 64.
89. Doty, R. L. The olfactory vector hypothesis of neurodegenerative disease: is it viable? Ann. Neurol., 2008, 63, 7-15.
90. Calderon-Garciduenas, L; Solt, A. C.; Henríquez-Roldán, C.; Torres-Jardón, R.; Nuse, B.; Herritt, L.; Villarreal-Calderón, R.; Osnaya, N.; Stone, I.; García, R.; Brooks, D. M.; González-Maciel, A.; Reynoso-Robles, R.; Delgado-Chávez, R.; Reed, W. Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults. Toxicol. Pathol., 2008, 36, 289-310.
91. Seifert, G.; Schilling, K.; Steinhäuser, C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci., 2006, 7, 194-206.
92. Damiani, C. L.; O'Callaghan, J. P. Recapitulation of cell signaling events associated with astrogliosis using the brain slice preparation. J. Neurochem., 2007, 100, 720-726.
93. Araneda, S.; Commin, L.; Atlagich, M.; Kitahama, K.; Parraguez, V. H.; Pequignot, J. M.; Dalmaz, Y. VEGF overexpression in the astroglial cells of rat brainstem following ozone exposure. Neurotoxicology, 2008, 29, 920-927.
94. Mrak, R. E; Griffin, W. S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging, 2005, 26(3):349-354.
95. Sama, P.; Long, T. C.; Hester, S.; Tajuba, J.; Parker, J.; Chen, L. C.; Veronesi, B. The cellular and genomic response of an immortalized microglia cell line (BV2) to concentrated ambient particulate matter. Inhal. Toxicol., 2007, 19, 1079-1087.
96. Blasko, I.; Stampfer-Kountchev, M.; Robatscher, P.; Veerhuis, R.; Eikelenboom, P.; Grubeck-Loebenstein, B. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell, 2004, 3, 169-176.
97. Zhang, P.; Hatter, A.; Liu, B. Manganese chloride stimulates rat microglia to release hydrogen peroxide. Toxicol. Lett., 2007, 173, 88-100.
98. Zhang, P.; Wong, T. A.; Lokuta, K. M.; Turner, D. E.; Vujisic, K.; Liu, B. Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation. Exp. Neurol., 2009, 217, 219-230.
99. Long, T. C.; Saleh, N.; Tilton, R. D.; Lowry, G. V.; Veronesi, B. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ. Sci. Technol., 2006, 40, 4346-4352.
100. Long, T. C.; Tajuba, J.; Sama, P.; Saleh, N.; Swartz, C.; Parker, J.; Hester, S.; Lowry, G. V.; Veronesi, B. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ. Health Perspect., 2007, 115, 1631-1637.
101. Ballabh, P.; Braun, A.; Nedergaard, M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis., 2004, 16(1), 1-13.
102. Cannon, J. R.; Greenamyre, J. T. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol. Sci., 2011, 124(2), 225-250.
103. Sonaje, K.; Lin, K. J.; Tseng, M. T.; Wey, S. P.; Su, F. Y.; Chuang, E. Y.; Hsu, C. W.; Chen, C. T.; Sung, H. W. Effects of chitosannanoparticlemediated tight junction opening on the oral absorption of endotoxins. Biomaterials, 2011, 32(33), 8712-8721.
104. Hoet, P. H.; Bruske-Hohlfeld, I.; Salata, O. V. Nanoparticles-known and unknown health risks. J. Nanobiotechnology, 2004, 2, 12.
105. Brooking, J.; Davis, S. S.; Illum, L. Transport of nanoparticles across the rat nasal mucosa. J. Drug Target., 2001, 9, 267-279.
106. Chen, L.; Yokel, R. A.; Hennig, B.; Toborek, M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune Pharmacol., 2008, 3, 286-295.
107. Hartz, A. M.; Bauer, B.; Block, M. L.; Hong, J. S.; Miller, D. S. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. FASEB J., 2008, 22, 2723-2733.
108. de Vries, H. E.; Kuiper, J.; de Boer, A. G.; Van Berkel, T. J. C.; Breimer, D. D. The Blood-Brain Barrier in Neuroinflammatory Diseases. Pharmacol. Rev., 1997, 49(2), 143-156.
109. Mattila, K. M.; Pirtilä, T.; Blennow, K.; Wallin, A.; Vitanen, M.; Frey, H. Altered blood-brain barrier function in Alzheimer's disease? Acta Neurol. Scand., 1994, 89, 192-198.
110. Tang, J.; Xiong, L.; Wang, S.; Wang, J.; Liu, L.; Li, J.; Yuan, F.; Xi, T. Distribution, translocation and accumulation of silver nanoparticles in rats. J. Nanosci. Nanotechnol., 2009, 9, 4924-4932.
111. Shemetov, A. A.; Nabiev, I.; Sokhanova, A. Molecular interaction of proteins and peptides with nanoparticles. ACS Nano, 2012, 6, 4585-4602.
112. Smita, S.; Gupta, S. K.; Bartonova, A.; Dusinska, M.; Gutleb, A. C.; Rahman, Q. Nanoparticles in the environment: Assessment using the causal diagram approach. Environ. Health, 2012, 11, 1-13.